Pro Medicus (OTCMKTS:PMCUF – Get Free Report) is expected to announce its results before the market opens on Tuesday, August 18th. Analysts expect Pro Medicus to post earnings of $0.4860 per share and revenue of $94.3880 million for the quarter.
Pro Medicus Price Performance
Shares of PMCUF opened at $122.00 on Tuesday. Pro Medicus has a 1 year low of $74.52 and a 1 year high of $210.25. The business’s 50 day simple moving average is $123.44 and its 200-day simple moving average is $105.53.
Analyst Ratings Changes
Separately, Jefferies Financial Group cut shares of Pro Medicus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 8th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $155.00.
Pro Medicus Company Profile
Pro Medicus Limited is an Australia?based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Featured Stories
- Five stocks we like better than Pro Medicus
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
